Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
about
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin.Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.Platelet support and the use of cytokines.Effect of low-dose granulocyte-macrophage colony-stimulating factor (LD-GM-CSF) on platelet transfusion-dependent thrombocytopenia.Regulatory mechanisms controlling hematopoiesis: principles and problems.Pathophysiology of pruritus in atopic dermatitis: an overview.Growth factors in ischemic stroke.New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.A primer on cytokines: sources, receptors, effects, and inducersThe potential role of recombinant hematopoietic colony-stimulating factors in preventing infections in the immunocompromised hostThe colony-stimulating factors and cancer.A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancerContinuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneouslyDisease states induced by hemopoietic growth factor excess: their implications in medicine.The impact of colony stimulating factors on cancer chemotherapy.G-CSF and GM-CSF in clinical trialsThe role of colony-stimulating factors in bone marrow transplantation.A (selective) history of Australian involvement in cytokine biology.The colony stimulating factors. Discovery, development, and clinical applications.The consequences of excess levels of haemopoietic growth factors.Early clinical trials with colony-stimulating factors.GM-CSF differentially regulates eosinophil and neutrophil adhesive interactions with vascular endothelium in vivo.Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor.Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).Cytokines as potential vaccine adjuvants.Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hematologic toxicity induced by high-dose chemotherapy in patients with metastatic breast cancer.Phase II study of glycosylated recombinant human granulocyte colony-stimulating factor after HLA-identical sibling bone marrow transplantation.Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome.Granulocyte-macrophage colony-stimulating factor (GM-CSF) primes the respiratory burst and stimulates protein biosynthesis in human neutrophils.Production of granulocyte-macrophage colony-stimulating factor in two patients with lung cancer, leukocytosis, and eosinophilia.Cytokines in hematopoiesis.Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in Hodgkin's disease.
P2860
Q33355632-874D4DFE-4070-4A04-9449-760FB836B6A9Q33372338-29142744-FEBB-4E16-A655-1381B083B5C1Q33488022-383A7E8E-A6F2-4705-8D1D-CE0B9D568F1BQ33491025-5F807AC0-FCF9-46C6-B925-7AAB7B9FC651Q34049495-49DB263F-BF88-4F1B-A639-70D9E2F0E489Q34600691-7DFB38A1-31D8-4644-B4F7-E7B46442F81AQ35216143-FD4390C5-F3EE-49B8-BBA8-9FFE43BFD43DQ35312342-F201EF5D-96C1-456A-849D-AE41AD0F3DB9Q35376246-A9279A4E-2F4D-4625-94F5-03E284156188Q35893155-8AC27A1F-3709-4903-95D0-A577DBA14A2CQ35936937-8685C4C9-71D0-4E81-8F61-FB8717B5718BQ35978222-49A99059-174F-4A03-A05F-95EA3A62CA29Q36140972-1F2F5A36-42B3-4C8A-81A9-8C94493E6157Q36567228-429E6477-31D6-4022-91B5-7D8055063050Q36591657-8A9E991C-3168-4E0A-8DD9-F94EEB5621F7Q36631539-16B43CD8-2918-441C-8657-7193C8A6AC7BQ36669960-684CC60B-9C70-40CA-AC3F-BE386F5F9E8DQ37018307-0D56E25E-4450-4279-8C6B-4A82D05D5F94Q37927086-2971F2F9-3302-4332-B897-4999291569F8Q37943348-DDBE2919-90B2-40DB-923B-CFAB997DBC1FQ38211736-BA42DDC8-DE4A-4D5A-9FB1-17F939FF3B81Q40069943-F99D08F8-4065-49DB-A4E6-9A887F7FC85AQ40488980-A8B3BB02-DA76-47DD-B501-BE656B7F8E0AQ40494019-943D1A9B-F95A-4EDD-B408-0573B937AD7FQ40598710-A50A8E0D-5489-4D26-950F-54804858D6BDQ40604674-15D01AF2-16E6-4B6B-A945-87B46D4659BFQ40692689-97BFD8B0-BE7A-4123-B013-EE50A31DFC4DQ40695936-DBA6C972-F07A-4720-BE61-9785B4C1DA20Q40712034-B741A785-AC0C-4D8B-88CE-520BFA8191AFQ40891327-677D94DB-7FFA-48F7-99A5-D3347401996AQ41645362-AA7AD5E7-BD02-415E-B8AE-D298A733993FQ43968850-49773C21-D228-4FD6-B450-654CF8337DB2Q45158619-09210592-FE9B-4D60-A1AB-9314B7CBC740Q46111987-14EB5473-25A9-4C19-A569-1AC6191EA58CQ47912530-4C5D248D-ACF5-40D9-9DCB-C7DD92451878Q54286027-E03ED763-471E-4E14-AEE3-6F2BC0C4B5A3
P2860
Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Effects of bacterially synthes ...... ents with advanced malignancy.
@en
type
label
Effects of bacterially synthes ...... ents with advanced malignancy.
@en
prefLabel
Effects of bacterially synthes ...... ents with advanced malignancy.
@en
P2093
P1476
Effects of bacterially synthes ...... ents with advanced malignancy.
@en
P2093
Lieschke GJ
O'Connor M
Rallings M
Sheridan W
P304
P356
10.7326/0003-4819-110-5-357
P407
P577
1989-03-01T00:00:00Z